2014
DOI: 10.3174/ajnr.a4080
|View full text |Cite
|
Sign up to set email alerts
|

Diffusivity Measurements Differentiate Benign from Malignant Lesions in Patients with Peripheral Neuropathy or Plexopathy

Abstract: BACKGROUND AND PURPOSE:Peripheral nerve disorders caused by benign and malignant primary nerve sheath tumors, infiltration or compression of nerves by metastatic disease, and postradiation neuritis demonstrate overlapping features on conventional MR imaging but require vastly different therapeutic approaches. We characterize and compare diffusivities of peripheral nerve lesions in patients undergoing MR neurography for peripheral neuropathy or brachial or lumbosacral plexopathy.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
10
0
2

Year Published

2015
2015
2022
2022

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 32 publications
(12 citation statements)
references
References 25 publications
0
10
0
2
Order By: Relevance
“…1.30 Â 10 À3 mm 2 /sec. 37 The relatively high ADC value of this particular vagal nerve neurofibroma (2 Â 10 À3 mm 2 /sec) was supportive of benign histology, correlating with the final pathology.…”
Section: Discussionmentioning
confidence: 60%
“…1.30 Â 10 À3 mm 2 /sec. 37 The relatively high ADC value of this particular vagal nerve neurofibroma (2 Â 10 À3 mm 2 /sec) was supportive of benign histology, correlating with the final pathology.…”
Section: Discussionmentioning
confidence: 60%
“…We excluded reviews, spinal cord studies and animal or in vivo studies. Our review identified a total of 35 articles: 24 DTI studies and 11 diffusionweighted MR neurography studies [31][32][33][34][35][36][37][38][39][40][41] . The number of lumbar nerve DTI studies has sharply increased in recent years ( Fig.…”
Section: Trends In Clinical Mr Neuroimaging Of Lumbar Nervesmentioning
confidence: 99%
“…criteria suggesting malignancy are heterogeneous enhancement or a sudden change in size and/or pattern of enhancement on follow-up examinations. As reported by Yuh et al, 37 diffusivity measurements may facilitate differentiation of benign from malignant tumors and from postradiation plexopathy. Using mean ADC values of 1.85 Â 10 3 mm 2 /s) for the diagnosis of benign lesions and 0.90 Â 10 3 mm 2 /s for the diagnosis of malignant tumors, Yuh et al were able to classify malignant and benign lesions correctly.…”
Section: Tumorsmentioning
confidence: 68%
“…However, because benign lesions and postradiation changes had similar ADC values, differentiation between the latter two conditions was not possible based on diffusivity measurements alone. 37 As mentioned earlier, MRI spectroscopy 18 can be useful for differentiating benign from malignant tumors because it allows detection of trimethylamine; nevertheless, quantification of trimethylamine is necessary to increase method specificity. 18 Fluorodeoxyglucose (FDG) PET/CT and, more recently, PET/MRI are good additions and should be performed in cases of suspected metastatic plexus involvement because high FDG uptake is typically seen in malignant tumors; absent or low FDG uptake, however, does not exclude the presence of a metastatic lesion.…”
Section: Tumorsmentioning
confidence: 99%